References
- Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
- JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 2014;78:2521-62. https://doi.org/10.1253/circj.CJ-66-0096
- Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33: 24-7. https://doi.org/10.1097/INF.0000000000000010
- Kang HJ, Kim GN, Kil HR. Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study. Korean J Pediatr 2013;56:389-95. https://doi.org/10.3345/kjp.2013.56.9.389
- Akagi T, Kato H, Inoue O, Sato N. Salicylate treatment in Kawasaki disease: high dose or low dose? Eur J Pediatr 1991;150:642-6. https://doi.org/10.1007/BF02072625
- Williams RV, Tcheng WY, Minich LL. Anticoagulation in the acute and long-term management of Kawasaki disease. Prog Pediatr Cardiol 2004:19:179-88. https://doi.org/10.1016/j.ppedcard.2004.08.012
- Israels SJ, Michelson AD. Antiplatelet therapy in children. Thromb Res 2006;118:75-83. https://doi.org/10.1016/j.thromres.2004.12.016
- Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10. https://doi.org/10.1111/j.1442-200X.1991.tb02612.x
- Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998;31:1074-80. https://doi.org/10.1016/S0735-1097(98)00033-3
- Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996;94:2103-6. https://doi.org/10.1161/01.CIR.94.9.2103
- Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-17. https://doi.org/10.1016/S0140-6736(06)68040-9
- Oh IJ, Moon KH, Hong ME, Kim YS, Lee CW, Yoon HS. Clinical significance of follow-up laboratory tests, performed at 6 weeks after the onset of Kawasaki disease. Korean J Pediatr 2006;49:672-6. https://doi.org/10.3345/kjp.2006.49.6.672
- Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78. https://doi.org/10.1542/peds.105.6.e78
- Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-80. https://doi.org/10.1067/mpd.2000.107890
- Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006;149:237-40. https://doi.org/10.1016/j.jpeds.2006.03.050
- Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma -globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007;166:131-7.
- Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T. External validation of a scoring system to predict resistance to intravenous immunoglobulin. J Pediatr 2007;150:e37. https://doi.org/10.1016/j.jpeds.2006.12.036
- Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics 1999;104:e57. https://doi.org/10.1542/peds.104.5.e57
- McMorrow Tuohy AM, Tani LY, Cetta F, Lewin MB, Eidem BW, Van Buren P, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol 2001;88:328-30. https://doi.org/10.1016/S0002-9149(01)01655-1